Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1226-1233
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1226
Table 1 Comparison of patients’ general data

Research (n = 65)
Control (n = 60)
t/χ2
P value
95%CI
Sex (male/female)39/2640/200.59620.44000.3610 to 1.5580
Average age (yr)64.66 ± 5.4566.63 ± 6.151.61320.1093-0.3856 to 3.8370
BMI (kg/m2)22.39 ± 1.7522.91 ± 1.841.61930.7079-0.1081 to 1.1630
Course of diabetes mellitus (yr)10.58 ± 1.9510.68 ± 2.740.23650.8135-1.1820 to 2.2130
NYHA grading of cardiac function125.03< 0.0001
I060
II190
III250
IV210
History of hypertension30250.25500.61360.5911 to 2.4360
Smoking history32231.50410.22010.7651 to 3.181
Table 2 Neutrophil-lymphocyte ratio and red blood cell distribution width levels in two groups

NLR
RDW
LVEF (%)
Research (n = 65)5.40 ± 1.7916.00 ± 1.6341.85 ± 7.23
Control (n = 60)2.99 ± 0.9813.88 ± 1.0858.07 ± 6.79
t9.22838.497612.9016
P value< 0.0001< 0.0001< 0.0001
95%CI-2.921 to -1.889-2.619 to -1.62913.73 to 18.71
Table 3 Comparison of general data in research groups with different cardiac function grades
NYHA classification
n
Male
Age (mean ± SD)
Course of diabetes mellitus
NLR
RDW
LEVF (%)
II19862.79 ± 4.8310.77 ± 1.833.91 ± 1.6414.72 ± 1.2545.82 ± 6.14
III251665.84 ± 5.8110.30 ± 1.965.55 ± 1.3115.53 ± 1.0442.75 ± 5.94
IV211565.71 ± 6.2510.75 ± 2.116.56 ± 1.4817.72 ± 0.9337.20 ± 7.23
F3.84521.86000.407016.430042.79009.3240
P value0.14630.16430.6674< 0.0001< 0.00010.0003
Table 4 Diagnostic efficiency of neutrophil-lymphocyte ratio and red blood cell distribution width

AUC
SE
Specificity (%)
Sensitivity (%)
95%CI
NLR0.8640.03390.075.40.799-0.929
RDW0.8590.03486.776.90.793-0.925
Joint detection0.9150.027100.076.90.863-0.968
Table 5 Comparison of neutrophil-lymphocyte ratio and red blood cell distribution width levels in patients with or without cardiac events

n
NLR
RDW
Without cardiac events464.97 ± 1.6615.70 ± 1.64
With cardiac events196.45 ± .6816.72 ± 1.42
t3.26102.3540
P value0.00180.0217